The global oral antiseptics market is estimated to garner a revenue of USD 4,662.3 million by the end of 2035 by growing at a CAGR of 4.9% over the forecast period, i.e., 2023 – 2035. Further, the market generated a revenue of USD 2,513.3 million in the year 2022. Growing awareness about oral hygiene and the increasing prevalence of oral care and diseases is expected to drive the global oral antiseptics market in the forecast period. With increasing awareness about the importance of oral hygiene, people are more likely to invest in oral care products, including antiseptics. Moreover, this has led to a rise in demand for oral antiseptics, particularly among people with dental problems, such as gum disease and cavities. For instance, according to the World Health Organization, more than 2 billion cases of caries in permanent teeth have been reported worldwide, with the average prevalence estimated to be 29%.
Oral cancer is indeed one of the factors that have driven the growth of the global oral antiseptic market. The increasing incidence of oral cancer has led to a growing demand for oral antiseptics, as people seek ways to maintain oral hygiene and prevent oral infections. For instance, according to the Centers for Disease Control and Prevention, in the US, 47,813 new instances of oral cavity and pharynx cancer were reported in 2019, and 10,492 people passed away from the disease. Moreover, the trend of e-cigarettes for tobacco products and marijuana, especially among youth and young adults, also represents a new growth factor for oral antiseptics as it is responsible for causing oral cancer.
Base Year |
2022 |
Forecast Year |
2023-2035 |
CAGR |
4.9% |
Base Year Market Size (2022) |
USD 2,513.3 million |
Forecast Year Market Size (2035) |
USD 4,662.3 million |
Regional Scope |
|
Growth Drivers
Challenges
The global oral antiseptics market is segmented and analyzed for demand and supply by chemical composition into chlorhexidine gluconate, cetylpyridinium chloride, herbs & essential oils, and others. Out of the four chemical compositions of the cetylpyridinium chloride segment is expected to contribute a share of 74.2% in 2022, and it is expected to grow at a CAGR of 5.2 % over the forecast period. The growth of the segment can be attributed to its diverse range of applications and effectiveness. Cetylpyridinium chloride is anticipated to exert a mechanism of action that reduces new dental plaque growth, reduces or removes existing dental plaque, diminishes the growth of pathogenic bacteria, and inhibits the production of virulence factors when added to mouthwashes, toothpaste, tablets, or mouth sprays. Furthermore, there has been an increase in the use of toothpastes or mouthwashes with a cetylpyridinium chloride formula among people, that is expected to boost the segment growth in the market. As per the reported study, mouthwash, and toothpastes with cetylpyridinium chloride counteract the virus that causes COVID-19 by 99 percent.
The global oral antiseptics market is also segmented and analyzed for demand and supply by application into treatment and prevention. Amongst these two segments, the prevention segment is expected to contribute the highest share of 68.8 % in terms of revenue in 2022, and it is predicted to grow at a CAGR of 5.1% over the forecast period. The rising adoption of oral antiseptics among youth for preventing oral infections is going to contribute to segment growth. An antibacterial mouthwash can effectively reduce and control plaque and gingivitis. Moreover, clinical studies have shown that even without mechanical teeth cleaning, an Octenident antiseptic can temporarily lower the bacterial load in the oral cavity and prevent plaque formation.
Our in-depth analysis of the global oral antiseptics market includes the following segments:
By Chemical Composition |
|
By Application |
|
By Form |
|
By Distribution Channel |
|
The market share of oral antiseptics in Asia Pacific excluding Japan, amongst the market in all the other regions, is projected to be the largest with a revenue of USD 1,875.1 Million in the year 2035, up from USD 897.3 Million in the year 2022. Moreover, it is expected to register the highest growth with a CAGR of 5.9% during the forecast period. The growth of the market can be attributed to the presence of large base of consumers for oral antiseptic products. Moreover, rising disposable income in the developing countries is further projected to rise the growth of the segment in the market. The Asia Pacific region also offers significant opportunities for companies well-positioned to meet the market's demands and provide high-quality oral antiseptics to customers. Furthermore, with growing demand for oral hygiene products and a strong focus on health and wellness, the Asia Pacific region is expected to continue to grow in the coming years. Moreover, the COVID-19 pandemic has led to an increased focus on health and wellness, and consumers have been seeking products to help them stay healthy and protect themselves against the virus. This has driven demand for oral antiseptics that are marketed as being effective against viruses and bacteria. For instance, a pre-procedure mouthwash containing oxidizing agents, such as 1% hydrogen peroxide or 0.2% povidone-iodine, is advised since SARS-CoV-2 is susceptible to oxidation. This will help to lower the microbial load in saliva and the potential for SARS-CoV-2 transmission.
The North America oral antiseptics market is expected to hold the second largest share by the end of 2035 with a revenue of USD 1,195.7 Million in the year 2035. This can be attributed to the surging incidence of oral cancer in the region, that is increasing the demand for oral antiseptics. Furthermore, the rising e-cigarettes trend among the youth in countries such as U.S is further expected to drive the growth of the market in the region. In addition, the North America region has large supermarkets, and drug stores that distribute oral antiseptics to the consumers. Hence, all these factors are predicted to rise the market’s growth in the region.
Moreover, the Europe oral antiseptics market is anticipated to show a significant growth with a revenue of USD 908.4 Million in the year 2035, up from USD 531.3 Million in the year 2022. The growth of the market can be attributed to the growing demand for these products, driven by increasing interest in oral hygiene. Moreover, there are many distributors of oral antiseptics in Europe, ranging from multinational companies to small regional players, that is further expected to boost the growth of the market in the region.
Avrio Health L.P. a subsidiary of Purdue Pharma L.P. (Purdue), announced the launch of Betadine Antiseptic Oral Rinse (Active Ingredients 0.5% Povidone Iodine or PVP-I), an oral antiseptic preoperative rinse.
Colgate-Palmolive Company acquired oral care company Hello Products LLC (“hello”) for USD $351 million in cash. The acquisition was financed with a combination of debt and cash. The acquisition is part of the company's focus strategy on the high-growth segments of Oral Care, Personal Care, and Pet Nutrition.
In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.
Author Credits: Radhika Gupta, Shivam Bhutani
Ans: Growing demand across emerging countries and the rising geriatric population are the major factors driving the market growth.
Ans: The market is anticipated to attain a CAGR of 4.9% over the forecast period, i.e., 2023 – 2035.
Ans: Side effects associated with oral antiseptics containing alcohol are estimated to be the growth-hindering factors for market expansion.
Ans: The market in the Asia Pacific excluding Japan region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Ans: The major players in the market are Procter & Gamble, Colgate-Palmolive Company, Johnson & Johnson Consumer Inc., OraCare and Church & Dwight Co., Inc., and others
Ans: The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.
Ans: The market is segmented by chemical composition, application, form, distribution channel, and by region.
Ans: The prevention segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Submit Your Request For Proposal (RFP)